[1]
Ozturk, F. et al. 2025. Successful Management of Steroid-Resistant cutaneous Acute Graft-versus-Host Disease, Toxic Epidermal Necrolysis-Like, with Ruxolitinib. Mediterranean Journal of Hematology and Infectious Diseases. 17, 1 (Feb. 2025), e2025020. DOI:https://doi.org/10.4084/MJHID.2025.020.